Parkinson's Disease

This hub offers a comprehensive exploration of Parkinson’s disease, integrating the latest scientific understanding, clinical practice, and emerging research. The linked articles cover the fundamentals of Parkinson’s disease pathophysiology, diagnosis, treatment strategies, and prognosis, while also examining associated conditions, genetic factors, and disease-modifying therapies. Readers will find evidence-based guidance on symptom management, including motor and non-motor features, along with in-depth discussions on neuroprotective interventions, the gut-brain axis, and the role of comorbidities. The collection also addresses the psychosocial impact of Parkinson’s disease, support resources, and advances in experimental therapies. Whether you are a healthcare professional, researcher, patient, or caregiver, these resources provide authoritative insights into the complex landscape of Parkinson’s disease.

Does Exercise Slow Parkinson's Disease Progression?

A growing pool of evidence suggests that high-intensity physical exercise may have beneficial outcomes in PD patients.

Uncovering Hidden Symptoms: Hallucinations and Delusions in Parkinson’s Disease

Parkinsonism in Spinocerebellar Ataxia

Do Antioxidants Benefit Patients with Alzheimer’s and Parkinson’s?

Estrogen as a Treatment for Parkinson’s Disease

Parkinson's Disease Support

What is Parkinson's Disease?

Mythbusting: Misconceptions surrounding Parkinson’s Disease

Parkinson's Compared to Dementia with Lewy Bodies (DLB)

Neurophysiotherapy for Parkinson's Disease

Parkinson's Disease Prognosis

Is Appendectomy Linked to Parkinson’s Disease?

See more featured articles »

Progressive Supranuclear Palsy (PSP) Versus Parkinson's Disease

Gut-Brain Axis and Neurodegenerative Disorders

Parkinson's Disease Research

Physiotherapy for Parkinson's Disease

Parkinson's Disease and Helicobacter Pylori

Impact of COVID-19 on Parkinson's Disease

Gut Bacteria Affecting Parkinson’s Treatment

Parkinson's Disease Diagnosis

Parkinson's Disease Treatment

Parkinson’s Disease and Sleeping Disorders

Parkinson's Disease Pathophysiology

Human brain may stay active for hours after death

Bipolar Disorder and Parkinson’s

Thalamotomy, Pallidotomy and Subthalamotomy

Where Does Parkinson’s Disease Originate?

Developing Drugs for Neurodegenerative Diseases

Herpes Virus and Parkinson's Disease

Parkinson's Disease and the Gut Microbiome

VPS35 Gene and Parkinson's Disease

Identifying Early Symptoms in Parkinson’s

Parkinson's Disease History

Gene Therapies for Parkinson’s Disease

Latest Parkinson's Disease News and Research

Researchers reveal common synaptic pathway behind Parkinson’s and Alzheimer’s diseases

Parkinson's and Alzheimer's diseases are the two most common neurodegenerative disorders, affecting millions of people worldwide.

4 Nov 2025

Loud noise exposure worsens motor deficits in Parkinson’s disease model

In the development of Parkinson's disease, it may not be a good idea to turn the amp to 11. High-volume noise exposure produced motor deficits in a mouse model of early-stage Parkinson's disease, and established a link between the auditory processing and movement areas of the brain, according to a study published November 4th in the open-access journal PLOS Biology by Pei Zhang from the Huazhong University of Science and Technology in Wuhan, China, and colleagues.

4 Nov 2025

USC researchers map genetic architecture of the human corpus callosum

For the first time, a research team led by the Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI) at the Keck School of Medicine of USC has mapped the genetic architecture of a crucial part of the human brain known as the corpus callosum-the thick band of nerve fibers that connects the brain's left and right hemispheres.

4 Nov 2025

GLP-1 drugs calm inflammation beyond diabetes and weight loss

This Journal of Clinical Investigation review describes how glucagon-like peptide-1 (GLP-1)–based medicines reduce systemic and tissue inflammation through both weight-dependent and weight-independent mechanisms. It details preclinical and clinical evidence linking GLP-1 receptor activation to cardiovascular, renal, hepatic, neural, and joint anti-inflammatory effects while outlining uncertainties and future research needs.

4 Nov 2025

Study reveals how "P bodies" heavily influence a cell's fate

How do stem cells know what to become? Nearly three decades after scientists isolated the first human embryonic stem cells, researchers are still working hard to understand precisely how a single, undifferentiated cell can become any one of the roughly 200 cell types that make up the human body.

4 Nov 2025

Personalized pain care could greatly improve life for Australians with Parkinson’s

Every 27 minutes, someone in Australia is diagnosed with Parkinson's disease. Best known for its tremors, movement and balance issues, it also brings another, often overlooked burden – persistent pain.

3 Nov 2025

Scientists create detailed single-cell map of the developing human brain

Scientists from Duke-NUS Medical School and their collaborators have created one of the most comprehensive single cell maps of the developing human brain. The atlas captures nearly every cell type, their genetic fingerprints, and how they grow and interact.

3 Nov 2025

Exploring the gut-brain-immune axis in neurodegeneration

Neurodegenerative diseases (NDs), such as Alzheimer's disease (AD), Parkinson's disease (PD), amyotrophic lateral sclerosis (ALS), and multiple sclerosis (MS), represent a growing global health burden, particularly in aging populations.

28 Oct 2025

Genetic analysis of blood sample could offer a non-invasive way for early Parkinson’s diagnosis

The genetic analysis of a blood sample could become a tool for the early diagnosis of Parkinson's disease, according to an exploratory study led by researchers from the Miguel Hernández University of Elche (UMH).

27 Oct 2025

Revolutionizing gait analysis with wearable sensors and 3D depth cameras

A study from the College of Engineering and Computer Science and the Sensing Institute (I-SENSE) at Florida Atlantic University reveals that foot-mounted wearable sensors and a 3D depth camera can accurately measure how people walk – even in busy clinical environments – offering a powerful and more accessible alternative to traditional gait assessment tools.

23 Oct 2025

Leveraging the microbiome to promote healthy living and aging

From probiotic pills to skincare products to dedicated meal plans, the microbiome is all the rage in the health and wellness space.

21 Oct 2025

Women with isolated REM sleep behavior disorder show lesser brain atrophy than men

A large international study involving nearly 700 participants reveals that women with a precursor condition to Parkinson's disease show significantly less brain atrophy—decreased cortical thickness in the brain—than men, despite similar clinical severity.

21 Oct 2025

Study reveals protein plaques in neurodegeneration function as enzymes, breaking down ATP

A new study led by Rice University's Pernilla Wittung-Stafshede has revealed that protein clumps, or plaques that clog the brain, associated with Parkinson's disease are not merely waste; they can actively drain energy from brain cells.

21 Oct 2025

World's largest-ever clinical trial launched to test treatments for Parkinson's disease

The world's largest-ever clinical trial of treatments to slow or stop the progression of Parkinson's disease has launched, led by researchers at UCL and Newcastle University.

16 Oct 2025

Advanced MRI technique reveals early markers of hereditary frontotemporal dementia

An international study led by researchers at Karolinska Institutet in Sweden demonstrates that it is possible to detect subtle changes in the brain and identify early signs of hereditary frontotemporal dementia using advanced brain imaging techniques.

16 Oct 2025